Skip to main content
Premium Trial:

Request an Annual Quote

CRB Distributing QuickAllAssay Reagents in UK

NEW YORK (GenomeWeb News) – Cambridge Research Biochemicals will distribute Bio-Nobile Products and Services' QuickAllAssay labeling reagents under a deal announced today.

The reagents are for labeling proteins, antibodies, and small molecules with a Europium chelate. According to CRB, the reagents are "unique" as only one kit is needed to label all assay formats including TR FRET (Time-Resolved Fluorescence Resonance Energy Transfer) and QRET (Quenched Resonance Energy Transfer assays), as well as separation-based enhanced time-resolved fluorescence assays.

QuickAllAssay kits can offer dual and triple label separation-based assays, CRB said, adding that lanthanides offer the possibility of creating multi-label measurements within the same well, making them "the perfect choice of label" for building such assays.

Financial and other terms of the deal were not disclosed.

"We believe having a unique kit for both homogeneous and separation assays which is significantly more sensitive and has a broader dynamic range in one easy to use kit will be of significant benefit to researchers," CRB Commercial Director Emily Humphrys said in a statement.

Based in Cleveland, UK, CRB manufactures and supplies specialized custom peptides and antibodies. Bio-Nobile is headquartered in Turku, Finland and manufactures, sells, and distributes sample preparation and data mining products targeting the genomics, proteomics, drug discovery, clinical chemistry, and cell biology markets.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.